Stay updated on DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial
Sign up to get notified when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.
Latest updates to the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page
- Check6 days agoNo Change Detected
- Check7 days agoChange DetectedThe page no longer lists the condition 'Multiple Myeloma' and the related topics 'MedlinePlus Genetics'.SummaryDifference0.2%
- Check14 days agoChange DetectedAdded related topics: 'Multiple myeloma' and 'MedlinePlus Genetics' to the page to provide quick access to disease context and genetics resources. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check21 days agoChange DetectedAdministrative revisions were made, updating from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check28 days agoChange DetectedRemoved the government funding notice banner and related topic links (Multiple Myeloma and MedlinePlus Genetics) from the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check43 days agoChange DetectedThe new screenshots show only visual changes to the Study Details page, including layout and formatting adjustments, with no modification to core study information such as title, inclusion/exclusion criteria, or outcomes.SummaryDifference0.5%
- Check50 days agoChange DetectedAdded related topics sections for 'Multiple myeloma' and 'MedlinePlus Genetics' on the page.SummaryDifference0.2%
Stay in the know with updates to DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.